Sanofi India Ltd.

8198.15 +244.05 ▲3.1%

28 March 2024, 04:01:00 PM
Volume: 1,069

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sanofiindialtd.com
Market Cap 18,696.83 Cr.
Enterprise Value(EV) 18,290.33 Cr. 2023-12
Financial Indicators
Earnings per share (EPS) 261.91 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 31.00 Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 440.95 Trailing Twelve Months Ending 2023-12
Price to Book Value 18.41 Calculated using Price: 8,118.25
Dividend Yield 2.06 Period Ending 2022-12
No. of Shares Subscribed 2.30 Cr. 23,030,622 Shares
FaceValue 10
About Sanofi India Ltd.
The company is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. The company prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. The company stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

Sanofi India Ltd. Delivery

Delivered Qty
Traded Qty

Sanofi India Ltd. Performance

1 Day
+3.07%
1 Week
+6.28%
1 Month
-8.98%
3 Month
+2.45%
6 Month
+15.40%
1 Year
+45.15%
2 Year
+11.66%
5 Year
+43.43%
10 Year
+175.95%

Sanofi India Ltd. Fundamental Ratios

9 years 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 2021-12 2022-12
Return on Equity (%) 18.7 20.68 17.43 16.87 18.18 18.07 21.39 44.65 36.73
Return on Capital Employed (%) 26.47 30.96 27.51 26.38 28.76 25.75 29.77 57.98 49.47
Return on Assets (%) 12.84 13.88 12.3 9.5 8.37 8.28 9.24 17.74 11.95

Sanofi India Ltd. Balance Sheet

Particulars 10 years 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2019-12 Rs. Cr. 2020-12 Rs. Cr. 2021-12 Rs. Cr. 2022-12 Rs. Cr. 2023-12* Rs. Cr.
Shh. Funds 1,486 1,627 1,883 2,026 2,219 2,442 2,119 2,226 1,276 1,016
Non Curr. Liab. 86 161 156 1,335 1,357 1,124 1,280 1,039 809 48
Curr. Liab. 656 617 502 962 1,193 1,674 1,694 2,290 2,743 651
Minority Int.
Equity & Liab. 2,228 2,405 2,541 4,324 4,769 5,240 5,093 5,555 4,828 1,715
Non Curr. Assets 965 1,161 966 2,519 2,608 2,141 2,253 1,876 1,215 469
Curr. Assets 1,263 1,244 1,575 1,805 2,162 3,099 2,841 3,675 3,612 1,246
Misc. Exp. not W/O
Total Assets 2,228 2,405 2,541 4,324 4,769 5,240 5,093 5,555 4,828 1,715

Sanofi India Ltd. Profit and Loss

Particulars 10 years 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2019-12 Rs. Cr. 2020-12 Rs. Cr. 2021-12 Rs. Cr. 2022-12 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,977 2,193 2,367 2,464 2,771 3,071 2,902 2,957 2,770 2,851
Other Income 64 51 66 81 90 94 90 75 73 65
Total Income 2,042 2,245 2,433 2,544 2,861 3,165 2,992 3,031 2,843 2,916
Total Expenditure -1,639 -1,734 -1,832 -1,926 -2,148 -2,405 -2,189 -2,194 -2,067 -2,047
PBIDT 403 511 602 618 713 759 803 837 776 869
Interest 0 0 -2 -1 -1 0 -2 -2 -2 -2
Depreciation -97 -113 -119 -102 -103 -100 -82 -67 -42 -40
Taxation -109 -159 -176 -189 -229 -186 -200 -313 -244 -243
Exceptional Items 67 84 -59 -42 489 132 18
PAT 264 322 304 326 381 414 478 944 621 603
Adjusted EPS 114 140 132 142 165 180 208 411 270 262

Sanofi India Ltd. Cash Flow

Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2019-12 Rs. Cr. 2020-12 Rs. Cr. 2021-12 Rs. Cr. 2022-12 Rs. Cr.
Cash Fr. Operatn. 273 265 213 322 435 374 412 611 559 399
Cash Fr. Inv. -335 61 36 -155 -79 -73 66 276 631 651
Cash Fr. Finan. -105 -122 -147 -180 -188 -197 -183 -810 -849 -1,583
Net Change -168 205 102 -13 168 104 295 78 341 -533
Cash & Cash Eqvt 261 466 568 554 722 825 1,120 1,197 1,538 1,005

Sanofi India Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 60.40 60.40 60.40 60.40 60.40 60.40 60.40 60.40 60.40
Public 39.60 39.60 39.60 39.60 39.60 39.60 39.60 39.60 39.60
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Sanofi India Ltd. Announcements

Thu, 28 Mar 2024
Closure of Trading Window
The Trading Window of the Company shall remain closed from 1st April 2024 till 48 hours after the announcement of the Financial Results of the Company for the quarter ended 31st March 2024 to the stock exchanges.
Thu, 28 Mar 2024
Announcement under Regulation 30 (LODR)-Resignation of Director
We wish to inform you that Mr. Marc-Antoine Lucchini (DIN: 08812302) Non-Executive Director has vide his letter dated 28th March 2024 resigned from the Board of Directors of the Company with effect from the close of business hours on 28th March 2024.
Tue, 26 Mar 2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a Press Release as regards to an exclusive distribution and promotion agreement between Sanofi India Limited (SIL) and Cipla Limited for distribution and promotion of SILs Central Nervous System products in India.

Sanofi India Ltd. Technical Scans

Thu, 28 Mar 2024
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone

Sanofi India Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Sanofi India Ltd. FAQ's

What is Sanofi India share price?

Can I buy Sanofi India shares now?

What is the Dividend Yield of Sanofi India?

What is the Market Cap of Sanofi India?

What are the key metrics to analyse Sanofi India?

What is the 52 Week High and Low of Sanofi India?

What is the trend of Sanofi India share price?